Selected research
Market Structure
Global Endocrine Therapy Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Endocrine Therapy Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Endocrine Therapy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Endocrine Therapy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Endocrine Therapy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Endocrine Therapy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Endocrine Therapy Medication include Chongqing Laimi Pharmaceutical Co., Ltd., Zhongpeptide Biochemical Co., Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Zhejiang Haizheng Pharmaceutical Co., Ltd., Changchun Jinsai Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd., Shenzhen Hanyu Pharmaceutical Co., Ltd., Shanghai Lizhu Pharmaceutical Co., Ltd. and Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Endocrine Therapy Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Endocrine Therapy Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Endocrine Therapy Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endocrine Therapy Medication market size, projected growth trends, production technologies, key applications, and end-use industries.
Endocrine Therapy Medication Segment by Company
Chongqing Laimi Pharmaceutical Co., Ltd.
Zhongpeptide Biochemical Co., Ltd.
Zhejiang Haizhou Pharmaceutical Co., Ltd.
Zhejiang Haizheng Pharmaceutical Co., Ltd.
Changchun Jinsai Pharmaceutical Co., Ltd.
Yangtze River Pharmaceutical Group Co., Ltd.
Shenzhen Hanyu Pharmaceutical Co., Ltd.
Shanghai Lizhu Pharmaceutical Co., Ltd.
Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
Shanghai Zhaohui Pharmaceutical Co., Ltd.
Maanshan Fengyuan Pharmaceutical Co., Ltd.
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Good Doctor Pharmaceutical Group Co., Ltd.
Dandong Yichuang Pharmaceutical Co., Ltd.
Chengdu Tiantaishan Pharmaceutical Co., Ltd.
Beijing Bornte Pharmaceutical Co., Ltd.
Teva
Pfizer
Janssen Biotech
Eli Lilly and Company
Dr. Reddy's
Cougar Biotechnology, Inc.
AstraZeneca
Endocrine Therapy Medication Segment by Type
Hormones and Related Drugs
Hormone Antagonists and Related Drugs
Endocrine Therapy Medication Segment by Application
Hospital
Clinic
Other
Endocrine Therapy Medication Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Therapy Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endocrine Therapy Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Therapy Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Endocrine Therapy Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Therapy Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Endocrine Therapy Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Endocrine Therapy Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Endocrine Therapy Medication Industry Trends
Table 2. Endocrine Therapy Medication Industry Drivers
Table 3. Endocrine Therapy Medication Industry Opportunities and Challenges
Table 4. Endocrine Therapy Medication Industry Restraints
Table 5. Global Endocrine Therapy Medication Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Endocrine Therapy Medication Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Endocrine Therapy Medication Sales by Manufacturers (K Units) & (2021-2026)
Table 8. Global Endocrine Therapy Medication Sales Market Share by Manufacturers
Table 9. Global Endocrine Therapy Medication Average Sales Price (US$/Unit) of Manufacturers (2021-2026)
Table 10. Global Endocrine Therapy Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Endocrine Therapy Medication Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Endocrine Therapy Medication Manufacturers, Product Type & Application
Table 13. Global Endocrine Therapy Medication Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Endocrine Therapy Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Hormones and Related Drugs
Table 17. Major Manufacturers of Hormone Antagonists and Related Drugs
Table 18. Global Endocrine Therapy Medication Sales by Type 2021 VS 2025 VS 2032 (K Units)
Table 19. Global Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units)
Table 20. Global Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units)
Table 21. Global Endocrine Therapy Medication Sales Market Share by Type (2021-2026)
Table 22. Global Endocrine Therapy Medication Sales Market Share by Type (2027-2032)
Table 23. Global Endocrine Therapy Medication Revenue by Type 2021 VS 2025 VS 2032 (K Units)
Table 24. Global Endocrine Therapy Medication Revenue by Type (2021-2026) & (K Units)
Table 25. Global Endocrine Therapy Medication Revenue by Type (2027-2032) & (K Units)
Table 26. Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2026)
Table 27. Global Endocrine Therapy Medication Revenue Market Share by Type (2027-2032)
Table 28. Major Manufacturers of Hospital
Table 29. Major Manufacturers of Clinic
Table 30. Major Manufacturers of Other
Table 31. Global Endocrine Therapy Medication Sales by Application 2021 VS 2025 VS 2032 (K Units)
Table 32. Global Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units)
Table 33. Global Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units)
Table 34. Global Endocrine Therapy Medication Sales Market Share by Application (2021-2026)
Table 35. Global Endocrine Therapy Medication Sales Market Share by Application (2027-2032)
Table 36. Global Endocrine Therapy Medication Revenue by Application 2021 VS 2025 VS 2032 (K Units)
Table 37. Global Endocrine Therapy Medication Revenue by Application (2021-2026) & (K Units)
Table 38. Global Endocrine Therapy Medication Revenue by Application (2027-2032) & (K Units)
Table 39. Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2026)
Table 40. Global Endocrine Therapy Medication Revenue Market Share by Application (2027-2032)
Table 41. Global Endocrine Therapy Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units)
Table 42. Global Endocrine Therapy Medication Sales by Region (2021-2026) & (K Units)
Table 43. Global Endocrine Therapy Medication Sales Market Share by Region (2021-2026)
Table 44. Global Endocrine Therapy Medication Sales Forecasted by Region (2027-2032) & (K Units)
Table 45. Global Endocrine Therapy Medication Sales Forecasted Market Share by Region (2027-2032)
Table 46. North America Endocrine Therapy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 47. North America Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 48. North America Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 49. Europe Endocrine Therapy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 50. Europe Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 51. Europe Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 52. Asia Pacific Endocrine Therapy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 53. Asia Pacific Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 54. Asia Pacific Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 55. South America, Middle East and Africa Endocrine Therapy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 56. South America, Middle East and Africa Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units)
Table 57. South America, Middle East and Africa Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units)
Table 58. Global Endocrine Therapy Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 59. Global Endocrine Therapy Medication Revenue by Region (2021-2026) & (US$ Million)
Table 60. Global Endocrine Therapy Medication Revenue by Region (2027-2032) & (US$ Million)
Table 61. Global Endocrine Therapy Medication Revenue Market Share by Region (2021-2026)
Table 62. Global Endocrine Therapy Medication Revenue Market Share by Region (2027-2032)
Table 63. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
Table 64. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
Table 65. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 66. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 67. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development
Table 68. Zhongpeptide Biochemical Co., Ltd. Company Information
Table 69. Zhongpeptide Biochemical Co., Ltd. Business Overview
Table 70. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 72. Zhongpeptide Biochemical Co., Ltd. Recent Development
Table 73. Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information
Table 74. Zhejiang Haizhou Pharmaceutical Co., Ltd. Business Overview
Table 75. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 77. Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Development
Table 78. Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information
Table 79. Zhejiang Haizheng Pharmaceutical Co., Ltd. Business Overview
Table 80. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 82. Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Development
Table 83. Changchun Jinsai Pharmaceutical Co., Ltd. Company Information
Table 84. Changchun Jinsai Pharmaceutical Co., Ltd. Business Overview
Table 85. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 87. Changchun Jinsai Pharmaceutical Co., Ltd. Recent Development
Table 88. Yangtze River Pharmaceutical Group Co., Ltd. Company Information
Table 89. Yangtze River Pharmaceutical Group Co., Ltd. Business Overview
Table 90. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 91. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 92. Yangtze River Pharmaceutical Group Co., Ltd. Recent Development
Table 93. Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information
Table 94. Shenzhen Hanyu Pharmaceutical Co., Ltd. Business Overview
Table 95. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 96. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 97. Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Development
Table 98. Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information
Table 99. Shanghai Lizhu Pharmaceutical Co., Ltd. Business Overview
Table 100. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 101. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 102. Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Development
Table 103. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
Table 104. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Business Overview
Table 105. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 106. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 107. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Development
Table 108. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
Table 109. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
Table 110. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 111. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 112. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Development
Table 113. Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information
Table 114. Maanshan Fengyuan Pharmaceutical Co., Ltd. Business Overview
Table 115. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 116. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 117. Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Development
Table 118. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
Table 119. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview
Table 120. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 121. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 122. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Development
Table 123. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
Table 124. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview
Table 125. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 126. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 127. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Development
Table 128. Good Doctor Pharmaceutical Group Co., Ltd. Company Information
Table 129. Good Doctor Pharmaceutical Group Co., Ltd. Business Overview
Table 130. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 131. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 132. Good Doctor Pharmaceutical Group Co., Ltd. Recent Development
Table 133. Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
Table 134. Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview
Table 135. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 136. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 137. Dandong Yichuang Pharmaceutical Co., Ltd. Recent Development
Table 138. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
Table 139. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview
Table 140. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 141. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 142. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Development
Table 143. Beijing Bornte Pharmaceutical Co., Ltd. Company Information
Table 144. Beijing Bornte Pharmaceutical Co., Ltd. Business Overview
Table 145. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 146. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
Table 147. Beijing Bornte Pharmaceutical Co., Ltd. Recent Development
Table 148. Teva Company Information
Table 149. Teva Business Overview
Table 150. Teva Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 151. Teva Endocrine Therapy Medication Product Portfolio
Table 152. Teva Recent Development
Table 153. Pfizer Company Information
Table 154. Pfizer Business Overview
Table 155. Pfizer Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 156. Pfizer Endocrine Therapy Medication Product Portfolio
Table 157. Pfizer Recent Development
Table 158. Janssen Biotech Company Information
Table 159. Janssen Biotech Business Overview
Table 160. Janssen Biotech Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 161. Janssen Biotech Endocrine Therapy Medication Product Portfolio
Table 162. Janssen Biotech Recent Development
Table 163. Eli Lilly and Company Company Information
Table 164. Eli Lilly and Company Business Overview
Table 165. Eli Lilly and Company Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 166. Eli Lilly and Company Endocrine Therapy Medication Product Portfolio
Table 167. Eli Lilly and Company Recent Development
Table 168. Dr. Reddy's Company Information
Table 169. Dr. Reddy's Business Overview
Table 170. Dr. Reddy's Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 171. Dr. Reddy's Endocrine Therapy Medication Product Portfolio
Table 172. Dr. Reddy's Recent Development
Table 173. Cougar Biotechnology, Inc. Company Information
Table 174. Cougar Biotechnology, Inc. Business Overview
Table 175. Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 176. Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio
Table 177. Cougar Biotechnology, Inc. Recent Development
Table 178. AstraZeneca Company Information
Table 179. AstraZeneca Business Overview
Table 180. AstraZeneca Endocrine Therapy Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 181. AstraZeneca Endocrine Therapy Medication Product Portfolio
Table 182. AstraZeneca Recent Development
Table 183. Key Raw Materials
Table 184. Raw Materials Key Suppliers
Table 185. Endocrine Therapy Medication Distributors List
Table 186. Endocrine Therapy Medication Customers List
Table 187. Research Programs/Design for This Report
Table 188. Authors List of This Report
Table 189. Secondary Sources
Table 190. Primary Sources
List of Figures
Figure 1. Endocrine Therapy Medication Product Image
Figure 2. Global Endocrine Therapy Medication Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Endocrine Therapy Medication Market Size (2021-2032) & (US$ Million)
Figure 4. Global Endocrine Therapy Medication Sales (2021-2032) & (K Units)
Figure 5. Global Endocrine Therapy Medication Average Price (US$/Unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Endocrine Therapy Medication Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Hormones and Related Drugs Image
Figure 9. Hormone Antagonists and Related Drugs Image
Figure 10. Global Endocrine Therapy Medication Sales by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 11. Global Endocrine Therapy Medication Sales Market Share 2021 VS 2025 VS 2032
Figure 12. Global Endocrine Therapy Medication Sales Market Share by Type (2021-2032)
Figure 13. Global Endocrine Therapy Medication Revenue by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 14. Global Endocrine Therapy Medication Revenue Market Share 2021 VS 2025 VS 2032
Figure 15. Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2032)
Figure 16. Hospital Image
Figure 17. Clinic Image
Figure 18. Other Image
Figure 19. Global Endocrine Therapy Medication Sales by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 20. Global Endocrine Therapy Medication Sales Market Share 2021 VS 2025 VS 2032
Figure 21. Global Endocrine Therapy Medication Sales Market Share by Application (2021-2032)
Figure 22. Global Endocrine Therapy Medication Revenue by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 23. Global Endocrine Therapy Medication Revenue Market Share 2021 VS 2025 VS 2032
Figure 24. Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2032)
Figure 25. North America Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 26. North America Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 27. U.S. Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 28. Canada Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 29. Mexico Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 30. Europe Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 31. Europe Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 32. Germany Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 33. France Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 34. U.K. Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 35. Italy Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 36. Netherlands Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 37. Asia Pacific Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 38. Asia Pacific Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 39. China Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 40. Japan Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 41. South Korea Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 42. Southeast Asia Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 43. India Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 44. Australia Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 45. South America, Middle East and Africa Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 46. South America, Middle East and Africa Endocrine Therapy Medication Sales Market Share by Country (2021-2032)
Figure 47. Brazil Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 48. South Africa Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 49. Saudi Arabia Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 50. Turkey Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 51. Argentina Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 52. UAE Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 53. Egypt Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 54. Chile Endocrine Therapy Medication Sales and Growth Rate (2021-2032) & (K Units)
Figure 55. Global Endocrine Therapy Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 56. Global Endocrine Therapy Medication Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 57. North America Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million)
Figure 58. North America Endocrine Therapy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 59. Europe Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million)
Figure 60. Europe Endocrine Therapy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 61. Asia-Pacific Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million)
Figure 62. Asia-Pacific Endocrine Therapy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 63. South America, Middle East and Africa Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million)
Figure 64. South America, Middle East and Africa Endocrine Therapy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 65. Endocrine Therapy Medication Value Chain
Figure 66. Manufacturing Cost Structure
Figure 67. Endocrine Therapy Medication Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Years Considered
Figure 71. Research Process
Figure 72. Key Executives Interviewed
Scope & coverage.
Types
- Hormones and Related Drugs
- Hormone Antagonists and Related Drugs
Applications
- Hospital
- Clinic
- Other
Companies covered
- Chongqing Laimi Pharmaceutical Co., Ltd.
- Zhongpeptide Biochemical Co., Ltd.
- Zhejiang Haizhou Pharmaceutical Co., Ltd.
- Zhejiang Haizheng Pharmaceutical Co., Ltd.
- Changchun Jinsai Pharmaceutical Co., Ltd.
- Yangtze River Pharmaceutical Group Co., Ltd.
- Shenzhen Hanyu Pharmaceutical Co., Ltd.
- Shanghai Lizhu Pharmaceutical Co., Ltd.
- Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
- Shanghai Zhaohui Pharmaceutical Co., Ltd.
- Maanshan Fengyuan Pharmaceutical Co., Ltd.
- Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Good Doctor Pharmaceutical Group Co., Ltd.
- Dandong Yichuang Pharmaceutical Co., Ltd.
- Chengdu Tiantaishan Pharmaceutical Co., Ltd.
- Beijing Bornte Pharmaceutical Co., Ltd.
- Teva
- Pfizer
- Janssen Biotech
- Eli Lilly and Company
- Dr. Reddy's
- Cougar Biotechnology, Inc.
- AstraZeneca
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Endocrine Therapy Medication Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Endocrine Therapy Medication Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Endocrine Therapy Medication Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Endocrine Therapy Medication Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Endocrine Therapy Medication Market Dynamics
- 2.1 Endocrine Therapy Medication Industry Trends
- 2.2 Endocrine Therapy Medication Industry Drivers
- 2.3 Endocrine Therapy Medication Industry Opportunities and Challenges
- 2.4 Endocrine Therapy Medication Industry Restraints
3 Endocrine Therapy Medication Market by Manufacturers
- 3.1 Global Endocrine Therapy Medication Revenue by Manufacturers (2021-2026)
- 3.2 Global Endocrine Therapy Medication Sales by Manufacturers (2021-2026)
- 3.3 Global Endocrine Therapy Medication Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Endocrine Therapy Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Endocrine Therapy Medication Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Endocrine Therapy Medication Manufacturers, Product Type & Application
- 3.7 Global Endocrine Therapy Medication Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Endocrine Therapy Medication Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Endocrine Therapy Medication Players Market Share by Revenue in 2025
- 3.8.3 2025 Endocrine Therapy Medication Tier 1, Tier 2, and Tier 3
4 Endocrine Therapy Medication Market by Type
- 4.1 Endocrine Therapy Medication Type Introduction
- 4.1.1 Hormones and Related Drugs
- 4.1.2 Hormone Antagonists and Related Drugs
- 4.2 Global Endocrine Therapy Medication Sales by Type
- 4.2.1 Global Endocrine Therapy Medication Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Endocrine Therapy Medication Sales by Type (2021-2032)
- 4.2.3 Global Endocrine Therapy Medication Sales Market Share by Type (2021-2032)
- 4.3 Global Endocrine Therapy Medication Revenue by Type
- 4.3.1 Global Endocrine Therapy Medication Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Endocrine Therapy Medication Revenue by Type (2021-2032)
- 4.3.3 Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2032)
5 Endocrine Therapy Medication Market by Application
- 5.1 Endocrine Therapy Medication Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Endocrine Therapy Medication Sales by Application
- 5.2.1 Global Endocrine Therapy Medication Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Endocrine Therapy Medication Sales by Application (2021-2032)
- 5.2.3 Global Endocrine Therapy Medication Sales Market Share by Application (2021-2032)
- 5.3 Global Endocrine Therapy Medication Revenue by Application
- 5.3.1 Global Endocrine Therapy Medication Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Endocrine Therapy Medication Revenue by Application (2021-2032)
- 5.3.3 Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2032)
6 Global Endocrine Therapy Medication Sales by Region
- 6.1 Global Endocrine Therapy Medication Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Endocrine Therapy Medication Sales by Region (2021-2032)
- 6.2.1 Global Endocrine Therapy Medication Sales by Region (2021-2026)
- 6.2.2 Global Endocrine Therapy Medication Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Endocrine Therapy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Endocrine Therapy Medication Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Endocrine Therapy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Endocrine Therapy Medication Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Endocrine Therapy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Endocrine Therapy Medication Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Endocrine Therapy Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Endocrine Therapy Medication Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Endocrine Therapy Medication Revenue by Region
- 7.1 Global Endocrine Therapy Medication Revenue by Region
- 7.1.1 Global Endocrine Therapy Medication Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Endocrine Therapy Medication Revenue by Region (2021-2026)
- 7.1.3 Global Endocrine Therapy Medication Revenue by Region (2027-2032)
- 7.1.4 Global Endocrine Therapy Medication Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Endocrine Therapy Medication Revenue (2021-2032)
- 7.2.2 North America Endocrine Therapy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Endocrine Therapy Medication Revenue (2021-2032)
- 7.3.2 Europe Endocrine Therapy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Endocrine Therapy Medication Revenue (2021-2032)
- 7.4.2 Asia-Pacific Endocrine Therapy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Endocrine Therapy Medication Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Endocrine Therapy Medication Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Chongqing Laimi Pharmaceutical Co., Ltd.
- 8.1.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
- 8.1.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
- 8.1.3 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.1.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
- 8.2 Zhongpeptide Biochemical Co., Ltd.
- 8.2.1 Zhongpeptide Biochemical Co., Ltd. Company Information
- 8.2.2 Zhongpeptide Biochemical Co., Ltd. Business Overview
- 8.2.3 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.2.5 Zhongpeptide Biochemical Co., Ltd. Recent Developments
- 8.3 Zhejiang Haizhou Pharmaceutical Co., Ltd.
- 8.3.1 Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information
- 8.3.2 Zhejiang Haizhou Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.3.5 Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments
- 8.4 Zhejiang Haizheng Pharmaceutical Co., Ltd.
- 8.4.1 Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information
- 8.4.2 Zhejiang Haizheng Pharmaceutical Co., Ltd. Business Overview
- 8.4.3 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.4.5 Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Developments
- 8.5 Changchun Jinsai Pharmaceutical Co., Ltd.
- 8.5.1 Changchun Jinsai Pharmaceutical Co., Ltd. Company Information
- 8.5.2 Changchun Jinsai Pharmaceutical Co., Ltd. Business Overview
- 8.5.3 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.5.5 Changchun Jinsai Pharmaceutical Co., Ltd. Recent Developments
- 8.6 Yangtze River Pharmaceutical Group Co., Ltd.
- 8.6.1 Yangtze River Pharmaceutical Group Co., Ltd. Company Information
- 8.6.2 Yangtze River Pharmaceutical Group Co., Ltd. Business Overview
- 8.6.3 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.6.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments
- 8.7 Shenzhen Hanyu Pharmaceutical Co., Ltd.
- 8.7.1 Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information
- 8.7.2 Shenzhen Hanyu Pharmaceutical Co., Ltd. Business Overview
- 8.7.3 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.7.5 Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Developments
- 8.8 Shanghai Lizhu Pharmaceutical Co., Ltd.
- 8.8.1 Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information
- 8.8.2 Shanghai Lizhu Pharmaceutical Co., Ltd. Business Overview
- 8.8.3 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.8.5 Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Developments
- 8.9 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
- 8.9.1 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
- 8.9.2 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Business Overview
- 8.9.3 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.9.5 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Developments
- 8.10 Shanghai Zhaohui Pharmaceutical Co., Ltd.
- 8.10.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
- 8.10.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
- 8.10.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.10.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
- 8.11 Maanshan Fengyuan Pharmaceutical Co., Ltd.
- 8.11.1 Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information
- 8.11.2 Maanshan Fengyuan Pharmaceutical Co., Ltd. Business Overview
- 8.11.3 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.11.5 Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Developments
- 8.12 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
- 8.12.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
- 8.12.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview
- 8.12.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.12.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments
- 8.13 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- 8.13.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
- 8.13.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview
- 8.13.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.13.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments
- 8.14 Good Doctor Pharmaceutical Group Co., Ltd.
- 8.14.1 Good Doctor Pharmaceutical Group Co., Ltd. Company Information
- 8.14.2 Good Doctor Pharmaceutical Group Co., Ltd. Business Overview
- 8.14.3 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.14.5 Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments
- 8.15 Dandong Yichuang Pharmaceutical Co., Ltd.
- 8.15.1 Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
- 8.15.2 Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview
- 8.15.3 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.15.5 Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments
- 8.16 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
- 8.16.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
- 8.16.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview
- 8.16.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.16.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments
- 8.17 Beijing Bornte Pharmaceutical Co., Ltd.
- 8.17.1 Beijing Bornte Pharmaceutical Co., Ltd. Company Information
- 8.17.2 Beijing Bornte Pharmaceutical Co., Ltd. Business Overview
- 8.17.3 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
- 8.17.5 Beijing Bornte Pharmaceutical Co., Ltd. Recent Developments
- 8.18 Teva
- 8.18.1 Teva Company Information
- 8.18.2 Teva Business Overview
- 8.18.3 Teva Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Teva Endocrine Therapy Medication Product Portfolio
- 8.18.5 Teva Recent Developments
- 8.19 Pfizer
- 8.19.1 Pfizer Company Information
- 8.19.2 Pfizer Business Overview
- 8.19.3 Pfizer Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Pfizer Endocrine Therapy Medication Product Portfolio
- 8.19.5 Pfizer Recent Developments
- 8.20 Janssen Biotech
- 8.20.1 Janssen Biotech Company Information
- 8.20.2 Janssen Biotech Business Overview
- 8.20.3 Janssen Biotech Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Janssen Biotech Endocrine Therapy Medication Product Portfolio
- 8.20.5 Janssen Biotech Recent Developments
- 8.21 Eli Lilly and Company
- 8.21.1 Eli Lilly and Company Company Information
- 8.21.2 Eli Lilly and Company Business Overview
- 8.21.3 Eli Lilly and Company Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Eli Lilly and Company Endocrine Therapy Medication Product Portfolio
- 8.21.5 Eli Lilly and Company Recent Developments
- 8.22 Dr. Reddy's
- 8.22.1 Dr. Reddy's Company Information
- 8.22.2 Dr. Reddy's Business Overview
- 8.22.3 Dr. Reddy's Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 Dr. Reddy's Endocrine Therapy Medication Product Portfolio
- 8.22.5 Dr. Reddy's Recent Developments
- 8.23 Cougar Biotechnology, Inc.
- 8.23.1 Cougar Biotechnology, Inc. Company Information
- 8.23.2 Cougar Biotechnology, Inc. Business Overview
- 8.23.3 Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio
- 8.23.5 Cougar Biotechnology, Inc. Recent Developments
- 8.24 AstraZeneca
- 8.24.1 AstraZeneca Company Information
- 8.24.2 AstraZeneca Business Overview
- 8.24.3 AstraZeneca Endocrine Therapy Medication Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.24.4 AstraZeneca Endocrine Therapy Medication Product Portfolio
- 8.24.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Endocrine Therapy Medication Value Chain Analysis
- 9.1.1 Endocrine Therapy Medication Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Endocrine Therapy Medication Production Mode & Process
- 9.2 Endocrine Therapy Medication Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Endocrine Therapy Medication Distributors
- 9.2.3 Endocrine Therapy Medication Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst